The Vdr: Why Your Vitamin D3 Might Not Be Protecting Your Ageing Brain
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Your brain has a waste-clearing system called the glymphatic system that works like a dishwasher, flushing out toxic proteins such as amyloid-beta and tau that accumulate during waking hours. This system runs at full power during deep sleep, when your brain cells shrink slightly and allow cleansing fluid to flow freely. When you lose sleep or sleep poorly, this rinse cycle slows dramatically, allowing toxic proteins to build up inside your brain.
Research shows that even a single night of poor sleep increases toxic protein levels in the brain by 35 to 55 percent and reduces the brain’s ability to clear them. Over time, chronic sleep disruption creates a vicious cycle: poor sleep allows proteins to accumulate, which then damages the brain structures responsible for regulating sleep, making sleep even worse. This cycle is particularly concerning because waiting until cognitive symptoms appear means the problem is already well established.
Good sleep quality depends on multiple coordinated biological rhythms: your heartbeat, breathing, brain wave patterns, circadian clock, and activity levels all work together to power glymphatic clearance. Disrupting any of these through late nights, irregular schedules, sedentary behavior, or sleep apnea ripples through and degrades the whole system. Practical steps include protecting seven to nine hours of quality sleep, maintaining a consistent sleep schedule, getting morning light, exercising regularly, and treating sleep apnea if present.
Verdict: Protecting your sleep quality is one of the most concrete, evidence-based things you can do for long-term brain health, as your brain depends on nightly sleep to clear the toxic proteins linked to Alzheimer’s disease.
What if the most powerful thing you could do for your long-term brain health isn’t a supplement, a diet, or a cognitive training app, but simply sleeping properly? And what if “simply” is doing a lot of heavy lifting in that sentence, because most of us aren’t doing it well enough? Here’s a thought that might stop you in your tracks: a single night of poor sleep measurably increases toxic amyloid-beta protein levels in your brain [14]. Not after a year of bad sleep. Not after a decade. One night. The research emerging from neuroscience labs over the past few years is quietly rewriting what we understand about Alzheimer’s disease, and it puts sleep right at the centre of the story. Not as a passive luxury, but as an active, biological cleaning cycle your brain absolutely depends on. Vitacuity has analysed over 1.77 million research papers and selected the most relevant for this topic. What follows is what we found.
To understand why sleep disruption matters so profoundly for brain health, you first need to understand a system most people have never heard of: the glymphatic system.
Think of it like a dishwasher for your brain. During waking hours, your neurons are constantly busy, firing, signalling, consuming energy, and producing metabolic waste products. One of those waste products is amyloid-beta (Aβ), the protein that clumps together to form the plaques characteristic of Alzheimer’s disease. Another is tau, a protein that, when misfolded, tangles inside neurons and disrupts their function. Left to accumulate, these are genuinely toxic to brain tissue [1].
The glymphatic system is a brain-wide waste clearance network, a kind of plumbing system built from the channels that run alongside blood vessels in the brain (called perivascular spaces). Cerebrospinal fluid (CSF) flows through these channels, flushing interstitial fluid, the fluid bathing your brain cells, and sweeping waste products out [6]. The key channel-keepers are specialised water-channel proteins called aquaporin-4 (AQP4), found on the “feet” of astrocytes (a type of brain support cell) that line the vessel walls. When AQP4 is functioning and polarised correctly, CSF flow is efficient and waste clearance is robust [1][6].
Here’s the critical part: this system is dramatically more active during sleep, particularly during deep, slow-wave sleep (also called non-rapid eye movement, or NREM sleep) [13]. During this phase, your brain cells actually shrink slightly, opening up the interstitial space and allowing CSF to flow more freely. The glymphatic “rinse cycle” runs at full power. When you’re awake, or when sleep is fragmented or insufficient, that rinse cycle slows dramatically, or stops altogether [4].
The brain, in other words, has a night shift. And if you keep cutting it short, the waste starts to pile up.
Evidence grade: Promising, direct human data, but small sample size (n=5)
In one of the more striking human studies on this topic, researchers at Washington University measured cerebrospinal fluid and blood plasma levels of amyloid-beta and tau in five cognitively normal individuals across two 36-hour periods, one with normal sleep, one with sleep deprivation, in a cross-over design [14].
The numbers were notable. During sleep deprivation, levels of Aβ40, Aβ42, and multiple tau variants increased by approximately 35% to 55% in the cerebrospinal fluid. At the same time, plasma (blood) levels of the same proteins dropped by around 5% to 15% [14]. This is important: it tells us the proteins weren’t just being produced at higher levels, the brain’s ability to *clear* them into the bloodstream was being actively impaired. The CSF-to-plasma ratio for all Alzheimer’s biomarkers increased significantly during sleep deprivation, while a measure of blood-brain barrier permeability actually decreased [14].
In plain English: one bad night of sleep caused toxic proteins to build up inside the brain and reduced the brain’s ability to flush them out. To be fair, this was a very small study, five people, and the effects of a single night are likely reversible. But as a window into the mechanism, it is quite telling. The direction of the findings is consistent with the broader body of evidence [2][13].
Evidence grade: Promising (animal models), Early stage (direct human causality)
The acute effects of one bad night are one thing. What happens when poor sleep becomes a chronic pattern is more alarming. Research from 2025 using a mouse model of Alzheimer’s disease (APP × PS1 mutant knock-in line) explored the interaction between chronic sleep-wake rhythm fragmentation and amyloid pathology [3].
The findings suggested that disrupted sleep-wake cycles can accelerate the development of AD-related brain pathology, including increased amyloid-beta levels. Interestingly, the research probed not just clearance but *production*, specifically looking at γ-secretase, an enzyme involved in generating Aβ peptides. The relationship between sleep disruption, Aβ production, and Aβ clearance appears more complex than simply “less sleep = less clearance” [3]. Sleep disruption may simultaneously increase production and reduce clearance, a compounding problem.
It is worth being transparent here: much of this mechanistic research has been done in animal models. The translation to humans, particularly the precise timelines and the magnitude of effect from chronic disruption, requires further investigation [3][5]. But the direction of evidence is consistent across multiple research groups, and the biological mechanism (glymphatic clearance during NREM sleep) has solid theoretical grounding [13].
Evidence grade: Promising, supported by mechanistic reviews and observational data
One of the more troubling aspects of this story is that the relationship between sleep disruption and Alzheimer’s pathology isn’t one-way. It’s a feedback loop, and a vicious one [2][5].
Poor sleep allows amyloid-beta and tau to accumulate. But as those proteins accumulate and Alzheimer’s pathology progresses, they begin to disrupt the very brain structures responsible for regulating sleep, including the suprachiasmatic nucleus (SCN), the brain’s master internal clock [12]. The result: Alzheimer’s pathology makes sleep worse, which allows more amyloid and tau to build up, which further damages sleep architecture, which allows still more accumulation. Round and round it goes [2][5].
This bidirectionality has an important implication: the earlier you protect sleep quality, the more you interrupt this cycle before it gathers momentum. Waiting until cognitive symptoms appear may mean the cycle is already well established [5][13].
Multiple 2025 review papers have also highlighted the role of circadian rhythm disruption specifically, not just sleep duration, but the *timing* and *regularity* of sleep, in driving this process. When circadian rhythms are misaligned, the coordinated release of melatonin, the regulation of cerebral blood flow, and the synchronisation of neural rhythms (particularly the slow delta waves of NREM sleep that drive glymphatic function) are all disrupted [12][4]. Microglial cells, the brain’s immune cells, also lose their circadian regulation, becoming more pro-inflammatory and contributing to neuroinflammation that further damages brain tissue [5][11].
Evidence grade: Early stage, mechanistic evidence from animal and laboratory research
The 2025 review on “organismal rhythmic activity” offers a fascinating expanded picture of what drives glymphatic efficiency [4]. It turns out that multiple overlapping rhythms in the body work together to power this clearance system:
– Cardiovascular rhythms: The pulsatility of arterial blood flow drives CSF movement through perivascular spaces. Heart rate variability and vessel wall health directly affect glymphatic transport efficiency [1][4]. – Respiratory rhythms: Breathing affects intracranial pressure and CSF circulation via changes in thoracic pressure. Disrupted breathing during sleep, as in obstructive sleep apnea, is therefore doubly damaging [4][13]. – Neural rhythms: The slow delta waves generated during deep NREM sleep synchronise neurovascular coupling and glia-vascular interactions, essentially “powering up” the glymphatic system [4][5]. – Circadian rhythms: These act as the coordinating conductor, regulating melatonin levels and cerebral blood flow and keeping all the other rhythms in sync [4][12]. – Exercise patterns: Physical activity influences the polarisation of AQP4 water channels, which directly affects how efficiently CSF flows through the perivascular network [4][6].
The research authors propose a framework they call “synchronised multiple rhythms”, the idea that optimal glymphatic function depends not on any single factor but on the harmonious coordination of all these biological rhythms together [4]. Disrupting any one of them, late nights, irregular sleep schedules, sedentary behaviour, poor cardiovascular health, sleep apnea, ripples through and degrades the others.
Evidence grade: Early stage to Promising, mainly animal studies with some human observational data
A 2020 review in *Brain Sciences* synthesised existing literature on lifestyle choices and glymphatic clearance, identifying several modifiable factors with meaningful mechanistic evidence [6]:
Sleep position: Some evidence suggests that sleeping on your side (lateral position) may facilitate more efficient glymphatic flow compared to sleeping on your back or front. This is based on animal studies and remains to be confirmed robustly in humans [6].
Alcohol: Chronic alcohol consumption has been shown to disrupt AQP4 polarisation and impair glymphatic function. While low doses in animals showed some initial glymphatic enhancement, chronic use was clearly detrimental [6]. This is not an argument for drinking.
Exercise: Physical activity appears to upregulate AQP4 polarisation and improve glymphatic efficiency. The timing of exercise may also matter, given the interaction with circadian rhythms [4][6].
Omega-3 fatty acids: Some evidence suggests omega-3 consumption may support glymphatic function, potentially through cardiovascular and vascular health pathways [6]. The human evidence here is thin; this is mechanistically plausible rather than proven.
Intermittent fasting and stress reduction: Both were identified as potentially modulating glymphatic clearance, though the human evidence remains early stage [6].
Evidence grade: Promising, consistent mechanistic evidence across multiple reviews
Obstructive sleep apnea (OSA) deserves specific mention because it combines several glymphatic insults simultaneously. It fragments sleep architecture (reducing NREM slow-wave sleep), causes intermittent hypoxia (oxygen deprivation), drives sympathetic nervous system hyperactivity, and has been associated with vascular damage in the brain [13].
A 2025 review of the clinical neurology literature specifically identified OSA as a condition that “fundamentally disrupts” glymphatic clearance, not merely correlating with poor cognitive outcomes but operating through a coherent, described biological mechanism [13]. The review’s conclusion was pointed: systematic diagnosis and effective management of sleep disorders represents a “tangible, accessible, and powerful strategy for primary and secondary neuroprotection” [13].
If you snore heavily, wake unrefreshed despite adequate hours in bed, or have been told you stop breathing during sleep, this is worth investigating with your GP. A sleep study is non-invasive and could be genuinely important.
Evidence grade: Early stage to Promising, mechanistic and observational data
For those who carry the APOE ε4 genetic variant, the most significant known genetic risk factor for late-onset Alzheimer’s disease, glymphatic health may be especially important. The 2025 review in *Alzheimer’s & Dementia* highlighted that the APOE ε4 allele disrupts meningeal lymphatic function (the system that drains CSF from the brain), directly increasing the risk of amyloid-beta accumulation through clearance deficits [1][7].
This doesn’t mean APOE ε4 carriers are destined for Alzheimer’s, most aren’t, but it does suggest that the modifiable lifestyle levers around sleep, circadian rhythm, and exercise may be especially valuable for those with this genetic background. If you know your APOE status and carry ε4, prioritising sleep quality isn’t optional self-care, it’s a meaningful risk-reduction strategy given current evidence [1][7].
Honesty matters here, so let’s be clear about the significant gaps in the current evidence.
Most of the mechanistic research is from animal models. The elegant experiments showing glymphatic flow increasing during sleep, or AQP4 polarisation changing with exercise, have been done primarily in mice. Translating these findings to humans, particularly quantifying the effect sizes and the timescales over which chronic disruption causes harm, requires substantially more human trial data [3][5][6].
The human studies are small. The most direct human evidence on sleep deprivation and Alzheimer’s biomarkers involved just five participants [14]. While the findings are directionally consistent with animal research and mechanistic predictions, we need larger, longer-duration human studies before we can speak with confidence about magnitude.
Causality in humans is complex. We know that poor sleep and higher amyloid burden co-occur. We have strong biological reasons to think the causal arrow runs (at least partly) from poor sleep to accumulation. But the bidirectionality of this relationship, where early Alzheimer’s pathology also disrupts sleep, makes it genuinely difficult to establish clean causal direction in observational human studies [2][5].
Optimal sleep dose is unknown. The research tells us that NREM slow-wave sleep is the critical phase for glymphatic function, but we don’t yet have human trial data telling us precisely how many hours, at what timing, or at what sleep architecture quality is needed to adequately clear amyloid burden over a lifetime [13].
Interventions targeting the glymphatic system directly are still experimental. Exciting approaches such as AQP4 modulation, meningeal lymphatic regeneration, and cervical lymphaticovenous anastomosis are discussed in the 2025 literature but remain in early research stages, not clinically available interventions for most people [1][7].
The sleep position finding needs human replication. The lateral sleep position hypothesis is based primarily on animal studies and has not been confirmed in adequately powered human trials [6].
Here is what a sensible, well-informed person should actually do with all of this.
The biological case for sleep as an active brain health intervention is now genuinely strong at the mechanistic level, even if the precise human quantification lags behind. The glymphatic system is real, its dependence on deep sleep is well-established in animal models and supported by human biomarker data, and the direction of all the evidence points the same way: chronic sleep disruption allows toxic proteins to accumulate in your brain, and good sleep clears them [1][2][13][14].
You don’t need to be paralysed by the gaps in the evidence to act on what we know.
Protect your sleep architecture, not just duration, but depth. Aim for seven to nine hours, but also aim for *quality*. Alcohol close to bedtime suppresses NREM slow-wave sleep, the very phase that powers glymphatic clearance [6]. That nightcap is not helping your brain. A consistent bedtime and wake time, even at weekends, protects your circadian rhythm, which coordinates the entire glymphatic machinery [12].
Get morning light exposure. This is the most powerful signal to your suprachiasmatic nucleus to anchor your circadian rhythm correctly [12]. It costs nothing and the downside risk is essentially zero.
Take sleep apnea seriously. If you suspect it, pursue it. This is not a minor inconvenience, it is a significant and treatable glymphatic risk factor [13].
Exercise regularly, and ideally not too late in the evening. The evidence for exercise improving AQP4 function and glymphatic efficiency is consistent enough across studies to act on, even without definitive human RCTs [4][6]. The benefit-risk ratio here is obviously favourable.
Consider your sleep position. The evidence is animal-model level and not definitive, but sleeping on your side has a mechanistically plausible case behind it, zero cost, and no downside. Worth trying [6].
On supplements: Omega-3 fatty acids have been suggested as supportive of glymphatic function via vascular pathways [6]. The evidence base here is thin for a direct glymphatic effect, but omega-3s have broad cardiovascular and brain health evidence behind them from other research, a practical supplement worth considering. Melatonin supplementation has been discussed in the circadian rhythm and AD literature as a potential tool for restoring circadian homeostasis [12], particularly for shift workers or those with significant circadian disruption. At low doses (0.5–3mg), melatonin is safe and generally well-tolerated. If your circadian rhythm is disrupted, late to sleep, difficulty waking, irregular schedules, a low-dose melatonin taken 30–60 minutes before the sleep time you’re trying to achieve is a reasonable, low-risk intervention that the evidence supports exploring.
The big picture: your brain has a cleaning cycle. It runs at night. Protecting it is one of the most concrete, mechanistically grounded things you can do for your long-term cognitive health. The research won’t be complete for years, but the direction is clear enough to act on now.
[1] Glymphatic and meningeal lymphatic dysfunction in Alzheimer’s disease: Mechanisms and therapeutic perspectives. (2025). DOI: 10.1002/alz.70709 | https://pubmed.ncbi.nlm.nih.gov/41152198/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568399/
[2] Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer’s disease. (2025). https://pubmed.ncbi.nlm.nih.gov/40189132/
[3] Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships. (2025). https://pubmed.ncbi.nlm.nih.gov/40222459/
[4] Effect of organismal rhythmic activity on Aβ clearance by the glymphatic system. (2025). DOI: 10.1186/s40001-025-03646-5 | https://pubmed.ncbi.nlm.nih.gov/41372777/
[5] Circadian Rhythm Disruption and Sleep Disorders in Alzheimer’s Disease: Mechanistic Insights and Therapeutic Potentials. (2025). https://pubmed.ncbi.nlm.nih.gov/40929704/
[6] The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices. (2020). *Brain Sciences.* DOI: 10.3390/brainsci10110868 | https://pubmed.ncbi.nlm.nih.gov/33212927/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698404/
[7] Glymphatic and meningeal lymphatic dysfunction in Alzheimer’s disease: Mechanisms and therapeutic perspectives. (2025) [duplicate reference, same paper as [1]]. DOI: 10.1002/alz.70709 | https://pubmed.ncbi.nlm.nih.gov/41152198/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568399/
[8] Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer’s disease. (2025) [duplicate reference, same paper as [2]]. https://pubmed.ncbi.nlm.nih.gov/40189132/
[9] Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships. (2025) [duplicate reference, same paper as [3]]. https://pubmed.ncbi.nlm.nih.gov/40222459/
[10] Effect of organismal rhythmic activity on Aβ clearance by the glymphatic system. (2025) [duplicate reference, same paper as [4]]. DOI: 10.1186/s40001-025-03646-5 | https://pubmed.ncbi.nlm.nih.gov/41372777/
[11] Circadian Rhythm Disruption and Sleep Disorders in Alzheimer’s Disease: Mechanistic Insights and Therapeutic Potentials. (2025) [duplicate reference, same paper as [5]]. https://pubmed.ncbi.nlm.nih.gov/40929704/
[12] The rhythm of decline: Circadian disruption in neurodegeneration. (2025). DOI: 10.38212/2224-6614.3553 | https://pubmed.ncbi.nlm.nih.gov/41066745/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510711/
[13] When sleep fails, brain clearance suffers: the role of glymphatic impairment in clinical neurology. (2025). DOI: 10.1007/s13760-025-02959-w | https://pubmed.ncbi.nlm.nih.gov/41315137/
[14] Acute sleep loss decreases CSF-to-blood clearance of Alzheimer’s disease biomarkers. (2023). *Alzheimer’s & Dementia.* DOI: 10.1002/alz.12930 | https://pubmed.ncbi.nlm.nih.gov/36695437/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366339/
[15] Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin. (2023). https://pubmed.ncbi.nlm.nih.gov/37783554/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
Quick Read Multiple large studies show that people who drink coffee regularly have lower rates of dementia and cognitive decline.
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.